Crossref
EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States
Value in Health · 2025-07 · 28 (6) · S138
DOI: 10.1016/j.jval.2025.04.2014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2025-07. Verfasst von Weiming (Ariel) Dong und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dong, W. A., & Bounthavong, M. (2025). EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States. Value in Health, 28(6), S138. https://doi.org/10.1016/j.jval.2025.04.2014
Vancouver
Dong WA, Bounthavong M. EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States. Value in Health. 2025;28(6):S138. doi:10.1016/j.jval.2025.04.2014
BibTeX
@article{Dong2025,
author = {Dong, Weiming (Ariel) and Bounthavong, Mark},
title = {EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States},
journal = {Value in Health},
year = {2025},
volume = {28},
number = {6},
pages = {S138},
doi = {10.1016/j.jval.2025.04.2014}
}
EUVIMED